NASDAQ: IMMX
IMMIX Biopharma Inc Stock Ownership - Who owns IMMIX Biopharma?

Insider buying vs selling

Have IMMIX Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jason HsuDirector2024-12-2340,000$2.19
$87.68kBuy
Jason HsuDirector2024-12-207,700$2.17
$16.68kBuy
Jason HsuDirector2024-08-228,100$2.25
$18.23kBuy
Jason HsuDirector2024-08-2115,000$2.23
$33.39kBuy
Carey NgDirector2024-08-1610,000$1.86
$18.60kBuy
Jason HsuDirector2024-07-246,000$2.15
$12.88kBuy
Jason HsuDirector2024-07-183,200$2.08
$6.64kBuy

1 of 1

IMMX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMMX insiders and whales buy or sell their stock.

IMMX Shareholders

What type of owners hold IMMIX Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Yekaterina Chudnovsky11.63%3,241,076$7.62MInsider
Ilya M. Rachman4.08%1,136,259$2.67MInsider
Carey Ng3.75%1,045,221$2.46MInsider
Jason Hsu3.38%943,000$2.22MInsider
Vladimir P. Torchilin3.25%905,200$2.13MInsider
Sean Senn3.23%899,800$2.11MInsider
Bleichroeder LP3.05%850,000$2.00MInstitution
Cable Car Capital LP2.80%779,358$1.83MInstitution
Vanguard Group Inc2.51%698,537$1.64MInstitution
Gabriel S. Morris1.11%309,975$728.44kInsider

1 of 3

IMMX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMMX10.47%31.44%Net Buying
MCRB47.82%52.18%Net SellingNet Selling
ANRO75.60%24.40%Net Buying
MNOV10.61%89.10%
IKNA67.86%18.22%

IMMIX Biopharma Stock Ownership FAQ

Who owns IMMIX Biopharma?

IMMIX Biopharma (NASDAQ: IMMX) is owned by 10.47% institutional shareholders, 31.44% IMMIX Biopharma insiders, and 58.09% retail investors. Yekaterina Chudnovsky is the largest individual IMMIX Biopharma shareholder, owning 3.24M shares representing 11.63% of the company. Yekaterina Chudnovsky's IMMIX Biopharma shares are currently valued at $7.62M.

If you're new to stock investing, here's how to buy IMMIX Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.